Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Universitaetsklinikum Freiburg patents


Recent patent applications related to Universitaetsklinikum Freiburg. Universitaetsklinikum Freiburg is listed as an Agent/Assignee. Note: Universitaetsklinikum Freiburg may have other listings under different names/spellings. We're not affiliated with Universitaetsklinikum Freiburg, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universitaetsklinikum Freiburg-related inventors


Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

The CD40L/Mac-1 interaction is selectively targeted by small peptide inhibitors and/or antibodies and such peptides are used for the specific treatment of inflammation and atherogenesis. In particular, pharmaceutical compositions comprising a polypeptide having the amino acid sequence EQLKKSKTL and antibodies specifically binding to an epitope are disclosed.... Universitaetsklinikum Freiburg








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universitaetsklinikum Freiburg in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universitaetsklinikum Freiburg with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###